POZEN, Inc.
1414 Raleigh Road
Suite 400
Chapel Hill,
NC 27517
United States - Map
Phone: 919-913-1030
Fax: 919-913-1039
Web Site: http://www.pozen.com
| POZEN, Inc. engages in the development of pharmaceutical products for the treatment of acute and chronic pain, and other pain-related conditions. The company has development and commercialization alliances with GlaxoSmithKline for Treximet, which is used for the acute treatment of migraine attacks with or without aura in adults; and AstraZeneca for proprietary fixed dose combinations of naproxen with the proton pump inhibitor esomeprazole magnesium in a single tablet for conditions, such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing non-steroidal anti-inflammatory drug-associated gastric ulcers. POZEN, Inc. was founded in 1996 and is headquartered in Chapel Hill, North Carolina. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. John R. Plachetka Pharm D., 55
Co-Founder, Chairman, Chief Exec. Officer and Pres |
$
1.27M |
$
0 | Mr. William L. Hodges CPA, 54
Chief Financial Officer and Sr. VP of Fin. & Admin. |
$
379.00K |
$
4.00K | Ms. Gilda M. Thomas , 54
Sr. VP, Sec. and Gen. Counsel |
$
352.00K | N/A | Mr. John E. Barnhardt , 59
Principal Accounting Officer and VP of Fin. & Admin. |
N/A
| N/A | Dr. Everardus Orlemans Ph.D., 52
Sr. VP of Product Devel. |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.34% Nasdaq 0.00%
Profile
